Abstract: A device for treating milk contained in a container is disclosed. The device comprises at least one heat source that comprises an air bath, a device for setting the container in motion and exposing the container to the heat source for a defined period of time, and a cooling source for cooling the milk.

Abstract: A building management system (1) for the control of plural actuators (10) arranged in a distributed manner, comprised of a central control unit (2) and at least one actuator (10) controlled by the central control unit (2), wherein the actuator (10) has a control device (11) which is formed to receive control commands from the central control unit (2) and to operate the actuator (10) in dependence upon these control commands, and a memory part (13) for storing function-relevant information. In accordance with the invention the memory part (13) is separate or separable from the control device (11).

Abstract: A method for treating milk, wherein milk is short-term heated in a container. At least during the heating, the container is set in motion in such a way that a milk film forms on the inner wall of the container. A device for carrying out the method is likewise described (FIG. 1).

Abstract: A building management system (1) for the control of plural actuators (10) arranged in a distributed manner, comprised of a central control unit (2) and at least one actuator (10) controlled by the central control unit (2), wherein the actuator (10) has a control device (11) which is formed to receive control commands from the central control unit (2) and to operate the actuator (10) in dependence upon these control commands, and a memory part (13) for storing function-relevant information. In accordance with the invention the memory part (13) is separate or separable from the control device (11).

Abstract: The invention relates to a method for treating infectious diseases which are elicited by viruses which are pathogenic to humans comprising the step of administering an amphiphilic nucleoside-phosphonoformic acid derivative having an esterified or unesterified carboxyl group, preferably of a nucleoside-glycerol-(hydroxycarbonyl)-phosphonate, as an active compound.

Abstract: A method for treating viral diseases which are caused by DNA viruses is described comprising administering an effective amount of at least one inhibitor of reverse transcriptase (RTI) in combination with at least one inhibitor of viral DNA polymerase, wherein the at least one RTI and the at least one DNA polymerase inhibitor are present in the form of separate compounds.

Abstract: A method for treating milk, wherein milk is short-term heated in a container. At least during the heating, the container is set in motion in such a way that a milk film forms on the inner wall of the container. A device for carrying out the method is likewise described (FIG. 1).

Abstract: The invention relates to a method for treating infectious diseases which are elicited by viruses which are pathogenic to humans comprising the step of administering an amphiphilic nucleoside-phosphonoformic acid derivative having an esterified or unesterified carboxyl group, preferably of a nucleoside-glycerol-(hydroxycarbonyl)-phosphonate, as an active compound.

Abstract: An enhancer has been located in the upstream region of the major immediate early gene of human cytomegalovirus and has been isolated, which enhancer is more active than that from SV40 and has a wide host cell spectrum. Hence, it is suitable for eukaryotic expression systems wherein it can be incorporated upstream or downstream of the structural gene or of the regulation region.

Abstract: Diagnostically relevant polypeptides and fusion proteins comprising an amino acid sequence which originates from cytomegalovirus and corresponds to a region of the major DNA-binding protein or of the C-terminal region of the tegument protein pp150 fused with at least one further fragment from another antigenic protein of cytomegalovirus are disclosed. The major DNA-binding protein is encoded by the reading frame UL57. The poly-peptides and fusion proteins according to the invention can be used in an advantageous manner in diagnostic tests and methods for the detection of IgM antibodies against cytomegalovirus.

Abstract: In order to control the luminosity in a room (1) lighted with several light sources (2a . . . , 3a . . . ) or several groups of light sources, a system is used with which the ratio between the light intensities of the individual light sources or groups of light sources can be adjusted or modified, and with which the total luminosity in the room (1) can be adjusted or modified while the ratio between the light intensities of the individual light sources or groups of light sources is kept constant. In particular for this purpose, a control device (7) is integrated in the system and connected to all operating devices (4a . . . , 5a . . . ) of the various light sources (2a . . . , 3a . . . ) to control the power consumption of the individual light sources (2a . . . , 3a . . . ).

Abstract: An enhancer has been located in the upstream region of the major immediate early gene of human cytomegalovirus and has been isolated, which enhancer is more active than that from SV40 and has a wide host cell spectrum. Hence, it is suitable for eukaryotic expression systems wherein it can be incorporated upstream or downstream of the structural gene or of the regulation region.

Abstract: The phosphorylated structural protein of molecular weight about 150 kd (pp 150) of human cytomegalovirus (HCMV) is highly immunogenic and is reliably recognised by human antisera. This protein can, after assignment and sequencing of the gene, be prepared, in whole or in immunogenic sections, by gene manipulation. Proteins of this type are suitable as reagents, for example in an ELISA, and as constituents of vaccines.

Abstract: The phosphorylated structural protein of molecular weight about 150 kd (pp 150) of human cytomegalovirus (HCMV) is highly immunogenic and is reliably recognised by human antisera. This protein can, after assignment and sequencing of the gene, be prepared, in whole or in immunogenic sections, by gene manipulation. Proteins of this type are suitable as reagents, for example in an ELISA, and as constituents of vaccines.

Abstract: A process is disclosed for replicating viruses of the HIV type which cause immune deficiency, in which process lymphocytes are employed which have been transformed with herpesvirus saimiri.

Abstract: A binding arrangement according to the present invention comprises a post projecting from one side of the arrangement and an opening having a blind ended mouth surrounded by a mouth wall for releasably securing the head of the post at the other side of the arrangement. The mouth is narrower and longer than the head which is stiff for forceably opening the mouth when it is inserted or removed from the secured position. The head has an undercut base for receiving the mouth wall when the head is locked in the opening. The overall arrangement is adapted to provide outward lateral flexing and inward lateral rebounding of the mouth wall at the undercut base of the head for removably securing the head in the opening.

Abstract: An improved binder, of one step construction manufactured from a single sheet of material comprising front and back covers, a backing disposed therebetween joining the covers and forming a continuation of the plane of the adjacent covers a plurality of fastening means, each fastening means formed integrally from one portion of one of said covers and forming a continuation of the plane of said cover at the juncture of the fastening means and the cover thereby presenting a cut-out portion in the cover corresponding to the shape of the fastening means when a part of the fastening means is lifted from the plane of the binder cover, each of said fastening means comprising a strap and tab, the strap forming a continuation of the plane of the cover at one end, the tab being disposed at the other end of the strap and forming a continuation of the plane thereof and of a width at the juncture with the strap to define therewith at least one locking shoulder, a plurality of slots disposed in said binder, one slot for eac

Abstract: A binder is provided manufactured in a single step operation from a single sheet of material and comprises front and back covers, a backing intermediate the two, and fastening means manufactured in one of the back covers and slot arrangements disposed adjacent to, or in, the backing to lock the fastening means. The binder is thus very inexpensive to manufacture and is easily used by industry in large quantities.

Abstract: A mailing pouch comprises a pouch mouth closure flap integral with one of the pouch walls. The closure flap has a resilient portion associated therewith which is sufficiently flexible to permit insertion and withdrawal of the flap into and from the pouch mouth. The resilient portion provides resistance to flap withdrawal to thereby provide a mailing pouch having a closure without the need for snap fastener, zipper or the like and is marginally susceptible to accidental opening during mail handling.